NOVT Novanta Inc
Company Analysis
Latest News
🔴 Novanta is trading 4.7% down today as technology stocks lead market pullback
Novanta is trading 4.7% down now at $160.80 as technology stocks lead a broader market pullback. - No clearly identified company-specific announcement...
🟢 Novanta is trading 9.64% up in pre-market; no clear catalyst identified
Novanta is trading 9.64% up at $185.01 in pre-market, with no clearly dated August 18, 2026 company announcement or reliable report directly explaining the...
🟢 Novanta is trading 5% up in pre-market; immediate catalyst remains unclear
Novanta is trading 4.94% up at $175.51, although no new company-specific announcement was identified for August 14, 2026. - August 5 second-quarter results...
🟢 Novanta is trading 5% up in pre-market after Q2 results and raised 2026 revenue guidance
Novanta is trading 5% up at $172.36 as investors react to its August 5 second-quarter results and upgraded outlook. - Revenue was $265.8 million and adjusted...
🟢 Novanta is trading 8.2% up in pre-market after Q2 results and raised full-year revenue guidance
Novanta is trading 8.2% up at $180.01 after investors continued reacting to its August 5 second-quarter earnings release. - Revenue reached $265.8 million,...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
🟢 Novanta is trading 4.08% up today after Q2 earnings beat and stronger full-year outlook
Novanta is trading 4.08% up at $169.99 after investors continued rewarding its August 5 earnings beat and stronger outlook. - Second-quarter revenue reached...
🟢 Novanta is trading 4.05% up today in pre-market on strong Q2 results and raised 2026 outlook
Novanta is trading 4.05% up now at $169.93 after strong second-quarter results and a raised 2026 outlook. - Revenue reached $265.8 million, adjusted EPS was...
🟢 Novanta is trading 13% up today after Q2 beat and raised 2026 guidance
Novanta is trading 12.91% up now at $172.89 after August 5, 2026, second-quarter results beat expectations. - Adjusted EPS was $0.89 versus $0.83 expected;...
🟢 Novanta is trading 5.9% up today after Q2 earnings beat and raised guidance
Novanta is trading 5.9% up now at $166.54 after its August 5 earnings release beat expectations. - Q2 revenue was $265.8 million, with adjusted EPS of...
🟢 Novanta is trading 4.49% up in pre-market after strong Q2 earnings and raised 2026 guidance
Novanta is trading 4.49% up at $160.00 after second-quarter results beat expectations. - Revenue reached $265.8 million, while adjusted EPS was $0.89 versus...
Novanta's second quarter revenue of $266M and EPS of $0.89 beat estimates, driven by strong 9.3% organic growth.
Novanta reported second quarter 2026 revenue of $265.8 million, up 10.3% year-over-year, with adjusted EPS increasing 17.1% to $0.89. Both figures surpassed...
🟢 Novanta is trading 5.6% up today ahead of Q2 earnings and amid a broader industrials rally
Novanta is trading 5.6% up at $156.29 as investors position ahead of its second-quarter 2026 earnings release scheduled for August 5, with consensus expecting...
Novanta Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
For the second quarter of 2026, consensus estimates place Novanta’s revenue at $262.1 million and adjusted EPS at $0.83, with the current stock price of...
🟢 Novanta is trading 4.05% up today amid a broader tech-led risk-on rally
Novanta is trading at $148.32 (up 4.05%), moving in line with a strong risk-on tone across U.S. equities. • Major indices are trending higher, led by a 2%...
🟢 Novanta is trading 4.1% up today amid broader risk-on sentiment and tech gains
Novanta is trading at $144.58 (+4.08%) today, with the move appearing to be driven by a broader risk-on tone in the market rather than company-specific...
Novanta Completes $1.45 Billion Acquisition of Medical Device Firm Riverpoint Medical
Novanta Inc. (NOVT) announced it has completed the acquisition of Riverpoint Medical, a manufacturer of minimally invasive surgical consumables. The...